66 related articles for article (PubMed ID: 3837943)
1. The correlation between the grading and nuclear size of renal cell carcinoma.
Kagawa S; Takigawa H; Kurokawa K; Akagi G
Tokushima J Exp Med; 1985 Dec; 32(3-4):45-8. PubMed ID: 3837943
[No Abstract] [Full Text] [Related]
2. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
[TBL] [Abstract][Full Text] [Related]
3. Computerized nuclear morphometry: prognostic value for carcinoma of the prostate and renal cell carcinoma.
Wenderoth UK; Gerlach B; Köppen A; Hautmann RE
Investig Urol (Berl); 1994; 5():16-9. PubMed ID: 7719300
[No Abstract] [Full Text] [Related]
4. Prognostic ability of simplified nuclear grading of renal cell carcinoma.
Rioux-Leclercq N; Karakiewicz PI; Trinh QD; Ficarra V; Cindolo L; de la Taille A; Tostain J; Zigeuner R; Mejean A; Patard JJ
Cancer; 2007 Mar; 109(5):868-74. PubMed ID: 17262800
[TBL] [Abstract][Full Text] [Related]
5. Classification strategies for the grading of renal cell carcinomas, based on nuclear morphometry and densitometry.
François C; Decaestecker C; Petein M; van Ham P; Peltier A; Pasteels JL; Danguy A; Salmon I; van Velthoven R; Kiss R
J Pathol; 1997 Oct; 183(2):141-50. PubMed ID: 9390025
[TBL] [Abstract][Full Text] [Related]
6. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.
Ficarra V; Martignoni G; Maffei N; Brunelli M; Novara G; Zanolla L; Pea M; Artibani W
Cancer; 2005 Jan; 103(1):68-75. PubMed ID: 15573369
[TBL] [Abstract][Full Text] [Related]
7. Nuclear morphometry in differential diagnosis of renal oncocytoma and renal cell carcinoma.
Castrén JP; Kuopio T; Nurmi MJ; Collan YU
J Urol; 1995 Oct; 154(4):1302-6. PubMed ID: 7658524
[TBL] [Abstract][Full Text] [Related]
8. [Oncocytomas of the kidney. Case reports and a review of the literature].
Wenzel M; Alles JU; Fischer HP; Kracht J; Pascu F; Stambolis C
Pathologe; 1986 Feb; 7(2):101-9. PubMed ID: 3703825
[No Abstract] [Full Text] [Related]
9. Tumor heterogeneity as prognostic factor in patients with low-stage (T1-3N0M0) renal-cell carcinoma.
van der Poel HG; Mulders PF; Oosterhof GO; Schaafsma HE; Hendriks JC; Schalken JA; Debruyne FM
Investig Urol (Berl); 1994; 5():60-5. PubMed ID: 7719322
[No Abstract] [Full Text] [Related]
10. Computerized nuclear morphometry of renal cell carcinomas.
Paraskevakou E; Kavantzas N; Pavlopoulos PM; Delibasis A; Yova D; Davaris P
Gen Diagn Pathol; 1996 Oct; 142(2):101-4. PubMed ID: 8950575
[TBL] [Abstract][Full Text] [Related]
11. Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma.
Fujikawa K; Sasaki M; Aoyama T; Itoh T
J Urol; 1997 Apr; 157(4):1237-41. PubMed ID: 9120910
[TBL] [Abstract][Full Text] [Related]
12. [Histological malignancy grade of renal cancer: karyo- and stereometric analysis].
Iurin AG; Koval'skiĭ GB
Arkh Patol; 2009; 71(2):13-8. PubMed ID: 19507571
[TBL] [Abstract][Full Text] [Related]
13. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
[TBL] [Abstract][Full Text] [Related]
14. Nuclear quantitative grading by discriminant analysis of renal cell carcinoma samples. A patient survival evaluation.
Artacho-Pérula E; Roldán-Villalobos R; Martínez-Cuevas JF; López-Rubio F
J Pathol; 1994 Jun; 173(2):105-14. PubMed ID: 8089804
[TBL] [Abstract][Full Text] [Related]
15. Chromophobe renal cell carcinoma with focal papillary configuration, nuclear basaloid arrangement and stromal osseous metaplasia containing fatty bone marrow element.
Kuroda N; Iiyama T; Moriki T; Shuin T; Enzan H
Histopathology; 2005 Jun; 46(6):712-3. PubMed ID: 15910607
[No Abstract] [Full Text] [Related]
16. [Morphological analysis of an atypical cytological picture in clear-cell carcinoma of the kidney].
Woyke S; Olszewski W; Gorczyca W
Patol Pol; 1984; 35(4):443-52. PubMed ID: 6535951
[No Abstract] [Full Text] [Related]
17. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
[TBL] [Abstract][Full Text] [Related]
19. Grading of renal cell carcinoma by 3D morphological analysis of cell nuclei.
Choi HJ; Choi HK
Comput Biol Med; 2007 Sep; 37(9):1334-41. PubMed ID: 17331492
[TBL] [Abstract][Full Text] [Related]
20. Correlation between size of renal cell carcinoma and its grade, stage, and histological subtype.
Tabibi A; Parvin M; Abdi H; Bashtar R; Zamani N; Abadpour B
Urol J; 2007; 4(1):10-3. PubMed ID: 17514604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
